Background:

Bacteriophages (phages) are viruses that can target and kill bacteria and are drawing renewed interest as potential treatments for bacterial infections, particularly as antibiotic resistance continues to rise. While advances in research and clinical experience have expanded interest in phage therapy, important scientific, clinical, and manufacturing challenges remain. This workshop will examine the current landscape, key barriers, and research priorities needed to support continued development and broader clinical use of phage therapy. 

Image

Objectives:

The workshop seeks to: 

• Review the current landscape of phage therapy development. 

• Identify key challenges and unmet needs.

• Highlight priorities for advancing development pathways and evidence generation.

• Foster alignment on the tools and considerations needed to support broader clinical use.

Countdown to the Event

See you in 98 days 14 hours 17 minutes
  • 98
    Days
  • 14
    Hours
  • 17
    Minutes
  • 28
    Seconds

Register By:
In-Person (Limited Space): October 10, 2026

Virtual: November 11, 2026